Skip to main content

Oncology Value Sets

NeoplasmObservationVS

Description TBD

Code Display CodeSystem
All codes descending from 108369006 Neoplasm (morphologic abnormality) http://snomed.info/sct

NeoplasmObservationMethodVS

Description TBD

Code Display CodeSystem
All codes descending from 386053000 Evaluation ProcedurePerformed http://snomed.info/sct

BreastCancerTypeVS

Description TBD

Code Display CodeSystem
All codes descending from 126926005 Neoplasm of the breast (disorder) http://snomed.info/sct

ReceptorVS

Description TBD

Code Display CodeSystem
All codes descending from 116647005 Receptor (substance) http://snomed.info/sct

NottinghamCombinedGradeVS

Description TBD

Code Display CodeSystem
369790002 Low grade or well differentiated http://snomed.info/sct
369791003 Intermediate/moderate grade or moderately differentiated http://snomed.info/sct
369792005 High grade or pooly differentiated http://snomed.info/sct

LymphSystemSubdivisionVS

A lymph node area or nodal group; a subdivision of the entire lymphatic system. For breast cancer, this includes 5 areas: internal mammary lymph nodes, axillary lymph nodes level I, II, and III, and the supraclavicular lymph nodes.

Code Display CodeSystem
All codes descending from 122490001 Lymphoid system structure (body structure) http://snomed.info/sct

HER2MethodVS

Description TBD

Code Display CodeSystem
74885-5 Tissue by Fluorescent in situ hybridization (FISH) http://loinc.org
spot-light SPot-Light HER2 CISH test HER2MethodCS
ihc ImmunoHistoChemistry test HER2MethodCS
inform Inform HER2 Dual ISH test (In SituHybridization) HER2MethodCS

DegreeOfLymphaticInvolvementVS

Description TBD

Code Display CodeSystem
microscopic Only a few cancer cells are in the node. DegreeOfLymphaticInvolvementCS
gross The cancer can be seen or felt without aid of microscopy. DegreeOfLymphaticInvolvementCS
extracapsular Cancer has pread outside the wall of the node. DegreeOfLymphaticInvolvementCS

GeneIdentifierVS

A unique code for a gene, including protein coding genes, ncRNA genes and pseudogenes, to allow unambiguous communication, drawn from HUGO Gene Nomenclature Committee.

Code Display CodeSystem
All codes found in CodeSystem http://www.genenames.org http://www.genenames.org http://www.genenames.org

RefseqVS

Description TBD

Code Display CodeSystem
All codes found in CodeSystem https://www.ncbi.nlm.nih.gov/refseq https://www.ncbi.nlm.nih.gov/refseq https://www.ncbi.nlm.nih.gov/refseq

TumorMarginDescriptionVS

Description TBD

Code Display CodeSystem
129738007 Lesion with circumscribed margin http://snomed.info/sct
129741003 Lesion with indistinct margin http://snomed.info/sct
129739004 Lesion with microlobulated margin http://snomed.info/sct
129740002 Lesion with obscured margin http://snomed.info/sct
129742005 Lesion with spiculated margin http://snomed.info/sct

StagingMethodVS

The methodology or standard used to do the staging.

Code Display CodeSystem
ajcc_v7 AJCC Breast Carcinoma Version 7 StagingMethodCS
ajcc_v8 AJCC Breast Carcinoma Version 8 StagingMethodCS

StagingTimeVS

When staging was done, relative to treatment events.

Code Display CodeSystem
clinical On initial diagnosis StagingTimeCS
pathologic Post-operative, after resection surgery StagingTimeCS
enrollment When patient is enrolled in a clinical trial StagingTimeCS
recurrence Upon recurrence of disease StagingTimeCS

TubuleFormationScoreVS

Description TBD

Code Display CodeSystem
369778004 Breast tubule formation: Majority of tumor >75% (score = 1) http://snomed.info/sct
369779007 Breast tubule formation: Moderate 10% to 75% (score = 2) http://snomed.info/sct
369780005 Breast tubule formation: Minimal <10% (score = 3) http://snomed.info/sct

NuclearPleomorphismScoreVS

Description TBD

Code Display CodeSystem
384735004 Nuclear pleomorphism: small regular nuclei (score=1) http://snomed.info/sct
384737007 Nuclear pleomorphism: moderate increase in size, etc (score = 2) http://snomed.info/sct
384738002 Nuclear pleomorphism: marked variation in size, nucleoli, chromatin clumping, etc (score = 3) http://snomed.info/sct

BrcaReceptorStatusVS

Classification of receptor status in breast cancer.

Code Display CodeSystem
luminal_A Group 1. Includes tumors that are ER positive and PR positive, but negative for HER2. Luminal A breast cancers are likely to benefit from hormone therapy and may also benefit from chemotherapy. BrcaReceptorStatusCS
luminal_B Group 2. Includes tumors that are ER positive, PR negative and HER2 positive. Luminal B breast cancers are likely to benefit from chemotherapy and may benefit from hormone therapy and treatment targeted to HER2. BrcaReceptorStatusCS
HER2_positive Group 3. Includes tumors that are ER negative and PR negative, but HER2 positive. HER2 breast cancers are likely to benefit from chemotherapy and treatment targeted to HER2. BrcaReceptorStatusCS
Triple_negative Group 4. Also called basal-like breast cancer, includes tumors that are ER negative, PR negative and HER2 negative. Basal-like breast cancers are likely to benefit from chemotherapy. BrcaReceptorStatusCS